TET2 and myeloproliferative neoplasm: The use of recent techniques such as next-generation sequencing (NGS) has defined panels of genetic abnormalities peculiar to MPN (comprising genes such as TP53, SF3B1, SRSF2, TET2, PTPN11, IDH2, EZH2, DNMT3A and others).